|
Phillip M. Satow was appointed to Noven�s Board of Directors in August 2007 upon the closing of Noven�s acquisition of JDS Pharmaceuticals, LLC. Mr. Satow was JDS�s co-founder and served as its Chief Executive Officer from inception in August 2004 through completion of the acquisition. After 15 years with Pfizer and three years as Vice President and General Manager of the Carter Wallace pharmaceutical business, Mr. Satow served as Executive Vice President of Forest Laboratories and President of its Forest Pharmaceuticals subsidiary. He established the marketing and sales departments at Forest, which he led for 14 years through the launch of Forest�s highly-successful antidepressant Celexa�. | 